Showing results (991-1000 of 1,683) with videos related to
Sort By:
Pageof 169
European Journal of Heart Failure|June 11, 2021
Influence of study discontinuation during the run-in period on the estimated efficacy of sacubitril/valsartan in the PARAGON-HF trialKota Suzuki, Brian Claggett, Masatoshi Minamisawa, et al.JACC. Heart Failure|January 10, 2016
Influenza Vaccination in Patients With Chronic Heart Failure: The PARADIGM-HF TrialOrly Vardeny, Brian Claggett, Jacob A Udell, et al.European Journal of Heart Failure|February 12, 2019
Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trialOrly Vardeny, Brian Claggett, Jessica Kachadourian, et al.JAMA Cardiology|November 29, 2018
Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF TrialPratyaksh K Srivastava, Brian L Claggett, Scott D Solomon, et al.Artificial Organs|August 20, 2022
The role of extracorporeal membrane oxygenation in adult kidney transplant patients: A qualitative systematic review of literatureTrista D Reid, Ian Kratzke, Diana Dayal, et al.Journal of Cardiac Failure|March 25, 2018
Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT TrialAkshay S Desai, Jiankang Liu, Marc A Pfeffer, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 6, 2010
Impaired skeletal muscle glucose uptake by [18F]fluorodeoxyglucose-positron emission tomography in patients with peripheral artery disease and intermittent claudicationReena L Pande, Mi-Ae Park, Todd S Perlstein, et al.Journal of the Chinese Medical Association : JCMA|April 2, 2019
Risk factors for hypogonadism in young men with erectile dysfunctionI-Shen Huang, Daniel J Mazur, Barbara E Kahn, et al.Diabetologia|November 4, 2017
Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trialJelena P Seferovic, Marc A Pfeffer, Brian Claggett, et al.Pageof 169